Litigation on Hepatitis B Vaccination and Demyelinating Disease in France: Breaking Through Scientific Uncertainty

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Borghetti, Jean-Sébastien
dc.date.issued 2012-03-09
dc.identifier.citation Borghetti, J-S. (2012). Litigation on Hepatitis B Vaccination and Demyelinating Disease in France: Breaking Through Scientific Uncertainty. A 'Workshop Incertesa i danys massius: causalitat i prova'. Girona: Universitat. [Consulta: 15 març 2012]. Disponible a: http://hdl.handle.net/10256.1/2430
dc.identifier.uri http://hdl.handle.net/10256.1/2430
dc.description.abstract Conferència de Jean-Sébastien Borghetti, professor de la Université Panthéon-Assas-Paris II, emmarcada dins el Workshop 'Incertesa i danys massius: causalitat i prova', organitzat pel Grup de Recerca de Filosofia del Dret, Institut de Dret Privat Europeu i Comparat i la Càtedra de Cultura Jurídica
dc.format.mimetype video/H263
dc.format.mimetype audio/mpeg
dc.language.iso eng
dc.publisher Universitat de Girona. Departament de Dret Privat
dc.relation.ispartofseries Workshop Incertesa i danys massius: causalitat i prova
dc.rights Aquest document està subjecte a una llicència Creative Commons: Reconeixement – No comercial – Compartir igual (by-nc-sa)
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/3.0/es/deed.ca
dc.subject Reparació (Dret) -- Congressos
dc.subject Litigis complexos -- Congressos
dc.subject Reparation -- Congresses
dc.subject Complex litigation -- Congresses
dc.title Litigation on Hepatitis B Vaccination and Demyelinating Disease in France: Breaking Through Scientific Uncertainty
dc.type info:eu-repo/semantics/lecture


Files in this item

The following license files are associated with this item:

Show simple item record

Related Items

Search DUGiMedia


Browse

My Account

Statistics

You can copy this text:

This file is restricted

The file you are attempting to access is a restricted file and requires credentials to view. Please login below to access the file.

  1. We will contact you via the email address you have provided us.